CooperVision has received FDA approval of its MiSight® 1 day contact lenses! Myopia is a condition in which close objects appear clearly, but far ones don't. MiSight® is meant to slow the progression of myopia in children and has been scientifically proven to reduce myopic progression by up to 59%. MiSight® 1 day lenses are the first FDA approved myopia management contact lenses and are expected to hit the market and be available for purchase in March of 2020.
“MiSight is a revolutionary product that can make a meaningful difference in the lives of children needing visual correction,” said President and CEO Al White. “Today’s approval is a big step forward for the ophthalmic industry as eye care professionals finally have an approved treatment for slowing the progression of myopia rather than just providing glasses or contact lenses to mask the condition. The increased incidence of myopia is a global epidemic so it’s exciting to see an FDA approved product which can now become the standard-of-care within the ophthalmic industry to treat this crisis.”
Modern Optometry offers several treatments for myopia. Call or schedule your appointment today.